Cancer and ageing: rival demons?
The DOI matches its Crossref record; 161 of the 161 references it cites were found in a registry or an index.
Abstract
Organisms with renewable tissues use a network of genetic pathways and cellular responses to prevent cancer. The main mammalian tumour-suppressor pathways evolved from ancient mechanisms that, in simple post-mitotic organisms, act predominantly to regulate embryogenesis or to protect the germline. The shift from developmental and/or germline maintenance in simple organisms to somatic maintenance in complex organisms might have evolved at a cost. Recent evidence indicates that some mammalian tumour-suppressor mechanisms contribute to ageing. How might this have happened, and what are its implications for our ability to control cancer and ageing?
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Several lines of evidence indicate that cellular senescence is a potent tumor-suppressive mechanism [ 4 , 9 , 10 ].”
From Senescence-Associated Secretory Phenotypes Reveal Cell-Nonautonomous Functions of Oncogenic RAS and the p53 Tumor Suppressor (2008) · cites this paper as [10]
In the citing paper
“Despite support for the idea that senescence is a beneficial anticancer mechanism, indirect evidence suggests that senescent cells can also be deleterious and might contribute to age-related pathologies [ 10 , 23 – 25 ].”
From Senescence-Associated Secretory Phenotypes Reveal Cell-Nonautonomous Functions of Oncogenic RAS and the p53 Tumor Suppressor (2008) · cites this paper as [10]
In the citing paper
“It is a cellular program which acts as a double-edged sword, with both beneficial and detrimental effects on the health of the organism, and considered to be an example of evolutionary antagonistic pleiotropy.”
From Mechanisms of Cellular Senescence: Cell Cycle Arrest and Senescence Associated Secretory Phenotype (2021) · cites this paper as Campisi, 2003
Citations
Cites
Hanahan, D., & Weinberg, R. A. (2000) · Cell · doi:10.1016/s0092-8674(00)81683-9 · Cited by 29,219
p53 Mutations in Human Cancers
Hollstein, M., Sidransky, D., Vogelstein, B., & Harris, C. C. (1991) · Science · doi:10.1126/science.1905840 · Cited by 8,018
A biomarker that identifies senescent human cells in culture and in aging skin in vivo.
Dimri, G. P., Lee, X., Basile, G., Acosta, M., Scott, G., Roskelley, C., Medrano, E. E., Linskens, M., Rubelj, I., & Pereira-Smith, O. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.20.9363 · Cited by 7,477
Apoptosis in the Pathogenesis and Treatment of Disease
Thompson, C. B. (1995) · Science · doi:10.1126/science.7878464 · Cited by 6,524 · cited 1×
“Apoptosis and ageing How might apoptosis contribute to ageing? In the somatic tissues of adult complex organisms, apoptosis is important for maintaining tissue homeostasis; defective apoptosis (either too little or too much) is associated with a number of disease”
BackgroundCDK inhibitors: positive and negative regulators of G1-phase progression
Sherr, C. J., & Roberts, J. M. (1999) · Genes & Development · doi:10.1101/gad.13.12.1501 · Cited by 6,115
Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a
Serrano, M., Lin, A. W., McCurrach, M. E., Beach, D., & Lowe, S. W. (1997) · Cell · doi:10.1016/s0092-8674(00)81902-9 · Cited by 5,218
Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours
Donehower, L. A., Harvey, M., Slagle, B. L., McArthur, M. J., Montgomery, C. A., Butel, J. S., & Bradley, A. (1992) · Nature · doi:10.1038/356215a0 · Cited by 4,649
Pleiotropy, natural selection, and the evolution of senescence.
Williams, G. C. (1957) · Evolution · doi:10.1111/j.1558-5646.1957.tb02911.x · Cited by 4,279
The regulation of E2F by pRB-family proteins.
Dyson, N. (1998) · Genes & Development · doi:10.1101/gad.12.15.2245 · Cited by 2,317
The microenvironment of the tumour–host interface
Liotta, L. A., & Kohn, E. C. (2001) · Nature · doi:10.1038/35077241 · Cited by 2,310
Research works printed but not linked: 2
- Prives, C. & Hall, P. A. The p53 pathway. J. Pathol. 187, 112–126 (1999). · doi:10.1002/(sici)1096-9896(199901)187:1<112::aid-path250>3.0.co;2-3
- Davenport, J. Tumor-free but not in the clear. Science, SAGE–KE, 2002.
Cited by
Items 201–300 of 511
Benítez, S., Cordero, A., Santamaría, P. G., Redondo-Pedraza, J., Rocha, A. S., Collado-Solé, A., Jimenez, M., Sanz-Moreno, A., Yoldi, G., Santos, J. C., et al. (2021) · Developmental Cell · doi:10.1016/j.devcel.2021.04.022 · Cited by 41
“Cellular senescence is a potent tumor-suppressive mechanism (Braig and Schmitt, 2006; Collins and Sedivy, 2003), induced by stress factors such as dysfunctional telomeres, DNA damage, and certain oncogenes (Campisi, 2003).”
BackgroundTrade-off between cancer and aging: What role do other diseases play?
Yashin, A. I., Ukraintseva, S. V., Akushevich, I. V., Arbeev, K. G., Kulminski, A. M., & Akushevich, L. (2008) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2008.03.006 · Cited by 43
Senescent cells at the crossroads of aging, disease, and tissue homeostasis
Kuehnemann, C., & Wiley, C. D. (2023) · Aging Cell · doi:10.1111/acel.13988 · Cited by 50
“As such, senescent cells may a consequence of antagonistic pleiotro-py— an evolutionary hypothesis that posits that traits that benefit an organism early in life might become detrimental later in life when selective pressure for the trait declines (Campisi, 2003b; Williams, 1957 ).”
BackgroundZhen, S., Chen, S., Geng, S., Hao, Z., Chen, Y., & Liu, B. (2022) · Foods · doi:10.3390/foods11050668 · Cited by 43
Fischer, F., Grigolon, G., Benner, C., & Ristow, M. (2022) · Physiological Reviews · doi:10.1152/physrev.00017.2021 · Cited by 45
Incorporating Basic Nutrition Science into Health Interventions for Cancer Prevention
Milner, J. A. (2003) · Journal of Nutrition · doi:10.1093/jn/133.11.3820s · Cited by 39
Sun, B., Huang, Q., Liu, S., Chen, M., Hawks, C. L., Wang, L., Zhang, C., & Hornsby, P. J. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-1376 · Cited by 41
“Overcoming the barrier of replicative senescence has often been thought to be essential for cancer formation (1– 4). Replicative senescence was originally described as a process that limits the growth of normal human cells in culture ( 4 , 5). The level of telomerase activity in most normal human cells is insufficient…”
BackgroundAging is associated with increased clonogenic potential in rat liver in vivo
Pasciu, D., Montisci, S., Greco, M., Doratiotto, S., Pitzalis, S., Pani, P., Laconi, S., & Laconi, E. (2006) · Aging Cell · doi:10.1111/j.1474-9726.2006.00230.x · Cited by 38
“However, the precise nature of this relationship is still unclear (Campisi, 2003; Balducci & Ershler, 2005).”
BackgroundSenescence; an endogenous anticancer mechanism
Vargas, J. E., Feltes, B. C., Poloni, J. D. F., Lenz, G., & Bonatto, D. (2012) · Frontiers in bioscience · doi:10.2741/4074 · Cited by 43
“All of these factors are responsible, to different degrees, for an increase in molecular damage and mutations that cause genetic instability and could lead to tumor development or aging (10).”
BackgroundToss, A., Venturelli, M., Peterle, C., Piacentini, F., Cascinu, S., & Cortesi, L. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18010085 · Cited by 42
Cirillo, G., Negrete-Diaz, F., Yucumá, D., Virtuoso, A., Korai, S. A., Luca, C. D., Kaniušas, E., Papa, M., & Panetsos, F. (2022) · Cells · doi:10.3390/cells11244103 · Cited by 41
“Increased ROS due to reduced capacity to regulate psychological stress can eventually damage DNA telomeres [76,77], resulting in cellular senescence [67,78,79].”
BackgroundXie, L., Tsaprailis, G., & Chen, Q. M. (2005) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m500032-mcp200 · Cited by 38
Reassessing the role of p53 in cancer and ageing from an evolutionary perspective
Aranda-Anzaldo, A., & Dent, M. A. R. (2007) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2007.01.001 · Cited by 36
Tissue engineering of skin and cornea: Development of new models for in vitro studies
Paquet, C., Larouche, D., Bisson, F., Proulx, S., Simard‐Bisson, C., Gaudreault, M., Robitaille, H., Carrier, P., Martel, I., Duranceau, L., et al. (2010) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2009.05373.x · Cited by 42
How hormones mediate trade-offs in human health and disease
Bribiescas, R. G., & Ellison, P. T. (2007) · Oxford University Press eBooks · doi:10.1093/acprof:oso/9780199207466.003.0007 · Cited by 40
Trosko, J. E. (2013) · The Anatomical Record · doi:10.1002/ar.22793 · Cited by 36
Trade-Offs Between Cancer and Other Diseases: Do They Exist and Influence Longevity?
Ukraintseva, S. V., Arbeev, K. G., Akushevich, I. V., Kulminski, A. M., Arbeeva, L. S., Culminskaya, I. V., Akushevich, L., & Yashin, A. I. (2010) · Rejuvenation Research · doi:10.1089/rej.2009.0941 · Cited by 37
Parikh, N., Shuck, R. L., Gagea, M., Shen, L., & Donehower, L. A. (2017) · Aging Cell · doi:10.1111/acel.12691 · Cited by 37
“Humans exhibit rapidly increasing cancer rates starting in the sixth decade of life (DePinho, 2000; Campisi, 2003).”
BackgroundThe Biology of Aging and Lymphoma: a Complex Interplay
Sarkozy, C., Salles, G. A., & Falandry, C. (2015) · Current Oncology Reports · doi:10.1007/s11912-015-0457-x · Cited by 37
Funasaka, T., Hu, H., Hogan, V. A., & Raz, A. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m706301200 · Cited by 35
Fragile fugue: p53 in aging, cancer and IGF signaling
Campisi, J. (2004) · Nature Medicine · doi:10.1038/nm0304-231 · Cited by 35
Self-citationShort telomeres: cause or consequence of aging?
Hornsby, P. J. (2006) · Aging Cell · doi:10.1111/j.1474-9726.2006.00249.x · Cited by 34
“Some have argued that short telomeres lead, in old age, to tissue malfunctions, the price we as a species pay for anticancer protection at younger ages (Campisi, 2003).”
BackgroundShort telomeres and high telomerase activity in T-cell prolymphocytic leukemia
Röth, A., Dürig, J., Himmelreich, H., Bug, S., Siebert, R., Dührsen, U., Lansdorp, P. M., & Baerlocher, G. M. (2007) · Leukemia · doi:10.1038/sj.leu.2404968 · Cited by 34
Shimizu, K., Shimizu, N. K., Hakamata, W., Unno, K., Asai, T., & Oku, N. (2010) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.33.117 · Cited by 35
McManus, F. P., Bourdeau, V., Acevedo, M., Lopes‐Paciencia, S., Mignacca, L., Lamoliatte, F., Pino, J. W. R., Ferbeyre, G., & Thibault, P. (2018) · Scientific Reports · doi:10.1038/s41598-018-25150-z · Cited by 33
Aging of the Human Adrenal Cortex
Hornsby, P. J. (2004) · Science of Aging Knowledge Environment · doi:10.1126/sageke.2004.35.re6 · Cited by 35
ΔNp53 or p44: priming the p53 pump
Scrable, H. J., Sasaki, T., & Maier, B. (2005) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2004.11.014 · Cited by 37
On evolutionary origin of cancer.
Lichtenstein, A. V. (2005) · Cancer Cell International · doi:10.1186/1475-2867-5-5 · Cited by 33
“A genetic program that has played a positive role in youth continues to be active in the older age, despite its possible counter-productive effects, simply "from force of inertia" because no correction mechanisms are available [53].”
Phylogeny of aging and related phenoptotic phenomena
Libertini, G. (2015) · Biochemistry (Moscow) · doi:10.1134/s0006297915120019 · Cited by 31
Declining cancer incidence at the oldest ages: Hallmark of aging or lower diagnostic activity?
Pedersen, J. K., Rosholm, J., Ewertz, M., Engholm, G., Lindahl‐Jacobsen, R., & Christensen, K. (2019) · Journal of Geriatric Oncology · doi:10.1016/j.jgo.2019.02.001 · Cited by 31
Cancer, aging and the optimal tissue design
Komarova, N. L. (2005) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2005.07.003 · Cited by 31
Physiological mechanisms of adaptive developmental plasticity in Rana temporaria island populations
Burraco, P., Valdés, A. E., Johansson, F., & Gómez-Mestre, I. (2017) · BMC Evolutionary Biology · doi:10.1186/s12862-017-1004-1 · Cited by 32
“However, telomere ends shorten over time after each cell division until critical telomere length is reached and initiates apoptosis, or programmed cell death [48].”
An age–period–cohort analysis of cancer incidence among the oldest old, Utah 1973–2002
Hanson, H. A., Smith, K. R., Stroup, A. M., & Harrell, C. J. (2014) · Population Studies · doi:10.1080/00324728.2014.958192 · Cited by 32
Han, Y., Kwon, J.-H., Yu, D., & Moon, E. (2006) · Free Radical Research · doi:10.1080/10715760600868552 · Cited by 34
p16 Is upregulated in proliferative inflammatory atrophy of the prostate
Faith, D., Han, S., Lee, D. K., Friedl, A., Hicks, J. L., Marzo, A. M. D., & Jarrard, D. F. (2005) · The Prostate · doi:10.1002/pros.20258 · Cited by 33
“Bypass or inactivation of this gene leads to an increase in population doublings and contributes to immortalization [37].”
Epithelial tissue architecture protects against cancer
Komarova, N. L., & Myint, P. C. (2006) · Mathematical Biosciences · doi:10.1016/j.mbs.2005.12.001 · Cited by 30
Milewski, L. A. K. (2010) · Bioscience Horizons The International Journal of Student Research · doi:10.1093/biohorizons/hzq001 · Cited by 33
“It is proposed that the primary function of the telomere system is its role as a natural defence against cancer.(29) The basic idea here is that telomere attrition restrains the growth of tumours by limiting the replicative capacities of transformed cells.”
BackgroundBehavior of Metastatic and Nonmetastatic Breast Tumors in Old Mice
Gravekamp, C., Sypniewska, R. K., Gauntt, S., Tarango, M., Price, P., & Reddick, R. (2004) · Experimental Biology and Medicine · doi:10.1177/153537020422900711 · Cited by 30
Guo, Y. P., Lu, Y., & Jin, H. (2020) · Scientific Reports · doi:10.1038/s41598-020-63909-5 · Cited by 30
Ibrahem, S., Ahmed, H. Q., & Zangana, S. (2022) · Annals of Saudi Medicine · doi:10.5144/0256-4947.2022.252 · Cited by 65
O’Nions, J., & Allday, M. J. (2004) · Journal of General Virology · doi:10.1099/vir.0.19704-0 · Cited by 34
“…Sun, 04 Aug 2019 02:57:52 Cells undergoing senescence display a progressive reduction of proliferation and eventually arrest, characterized by an increase in the levels of markers including p53, p21WAF1/CIP1, p14ARFand p16INK4A (Campisi, 2003; Mathon & Lloyd, 2001; Sherr & DePinho, 2000).”
BackgroundEvolutionary origins of human apoptosis and genome-stability gene networks
Castro, M. A. A., Dalmolin, R. J. S., Moreira, J. C. F., Mombach, J. C. M., & de Almeida, R. M. C. (2008) · Nucleic Acids Research · doi:10.1093/nar/gkn636 · Cited by 34
“Senescence is an alternative tumor suppressor mechanism, where damaged cells are prevented from dividing ( 67 ).”
Gu, J. H., Spitz, M. R., Zhao, H., Lin, J. M., Grossman, H. B., Dinney, C. P., & Wu, X. (2005) · Carcinogenesis · doi:10.1093/carcin/bgi126 · Cited by 32
“Tumor suppressor genes can be generally grouped into two classes: caretakers, which act to protect the genome from damage and mutation, and gatekeepers, which function to prevent the proliferation of potential cancer cells by inducing either cellular senescence or apoptosis (1).”
BackgroundReece, A. S., & Hulse, G. K. (2022) · Archives of Public Health · doi:10.1186/s13690-022-00811-8 · Cited by 26
UVB-Induced Microvesicle Particle Release and Its Effects on the Cutaneous Microenvironment
Frommeyer, T. C., Gilbert, M. M., Brittain, G. V., Wu, T., Nguyen, T. Q., Rohan, C. A., & Travers, J. B. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.880850 · Cited by 32
“induce formation of cyclobutane pyrimidine dimers which have the potential to be propagated to subsequent cellular populations, which may result in pro-carcinogenic changes (8, 9).”
BackgroundEvolution, developmental plasticity, and metabolic disease
Kuzawa, C. W., Gluckman, P. D., Hanson, M. A., & Beedle, A. S. (2007) · Oxford University Press eBooks · doi:10.1093/acprof:oso/9780199207466.003.0019 · Cited by 29
Schizophrenia as segmental progeria
Papanastasiou, E., Gaughran, F., & Smith, S. M. (2011) · Journal of the Royal Society of Medicine · doi:10.1258/jrsm.2011.110051 · Cited by 35
Deregulation of the Cell Cycle by the Epstein–Barr Virus
O’Nions, J., & Allday, M. J. (2004) · Advances in cancer research · doi:10.1016/s0065-230x(04)92006-4 · Cited by 32
Variation in the SHC1 gene and longevity in humans
Mooijaart, S. P., van Heemst, D., Schreuder, J., van Gerwen, S., Beekman, M., Brandt, B. W., Slagboom, P. E., & Westendorp, R. G. J. (2003) · Experimental Gerontology · doi:10.1016/j.exger.2003.10.001 · Cited by 31
“Apoptosis (Campisi, 2003) and reactive oxygen species (Martin et al., 1996) have been suggested to play a role in human longevity.”
BackgroundDucasse, H., Arnal, A., Vittecoq, M., Daoust, S. P., Újvári, B., Jacqueline, C. M., Tissot, T., Ewald, P. W., Gatenby, R. A., King, K. C., et al. (2015) · Evolutionary Applications · doi:10.1111/eva.12232 · Cited by 29
“This undoubtedly explains why complex organisms evolved many potent cancer suppression mechanisms (at least through the period of sexual maturity and reproduction, Campisi 2003).”
BackgroundPleil, J. D., Williams, M. A., & Sobus, J. R. (2012) · Toxicology Letters · doi:10.1016/j.toxlet.2012.10.011 · Cited by 26
“…in the senior population; for example, point mutations are less likely to proliferate into tumors due to slowed cellular reproductive rates and less efficient metabolism, and germ-line mutations are unlikely to be passed forward (Campisi, 2003; Mays Hoopes, 2010; Sartorius and Nieschlag, 2010).”
BackgroundKubis-Kubiak, A., & Piwowar, A. (2015) · Ageing Research Reviews · doi:10.1016/j.arr.2015.07.008 · Cited by 31
Lifestyle, diet, and disease: comparative perspectives on the determinants of chronic health risks
Leonard, W. R. (2007) · Oxford University Press eBooks · doi:10.1093/acprof:oso/9780199207466.003.0020 · Cited by 35
Shao, Z., Zhang, X., Fan, H.-H., Wang, X.-S., Wu, H., Zhang, L., Cheng, W., & Zhu, J. (2019) · Journal of Nutrition · doi:10.1093/jn/nxz199 · Cited by 25
Kwon, Y., & Magnuson, B. A. (2008) · Food and Chemical Toxicology · doi:10.1016/j.fct.2008.11.035 · Cited by 26
He, D., Liu, L., Zhang, Z., Yang, X., Jia, Y., Wen, Y. F., Cheng, S., Meng, P., Li, C., Zhang, H., et al. (2022) · BMC Microbiology · doi:10.1186/s12866-022-02703-x · Cited by 26
“Tumor-suppressor genes can be classified as longevity assurance genes, and cancer was considered a natural ceiling on human longevity and its incidence rose exponentially with age [57].”
BackgroundAging genomes: A necessary evil in the logic of life
Vijg, J. (2014) · BioEssays · doi:10.1002/bies.201300127 · Cited by 25
“Like apoptosis, cellular senescence is antagonistically pleiotropic, since it suppresses cancer at early age, but at the cost of promoting aging at later ages, for example, by exhausting progenitor or stem cell reservoirs [48, 49].”
BackgroundOff-target response of a Wip1 chemical inhibitor in skin keratinocytes
Lee, J., Park, J., Kwon, O., Kim, S., Fornace, A. J., & Cha, H. (2013) · Journal of Dermatological Science · doi:10.1016/j.jdermsci.2013.09.003 · Cited by 27
Zhdanov, D. D., Gladilina, Y. A., Grishin, D. V., Grachev, V. A., Orlova, V. S., Pokrovskaya, M. V., Alexandrova, S. S., Pokrovsky, V. S., & Sokolov, N. N. (2018) · Molecular Immunology · doi:10.1016/j.molimm.2018.07.017 · Cited by 25
“These data correspond with the observation that telomere length varies among the cell populations and even in the chromosomes within the same cell; thus, so cellular senescence can be achieved when telomeres reach a critical size that has been estimated at less than 6000 bp (Campisi, 2003).”
BackgroundGenetic regulation of thymocyte progenitor aging
Berent-Maoz, B., Montecino-Rodriguez, E., & Dorshkind, K. (2012) · Seminars in Immunology · doi:10.1016/j.smim.2012.04.006 · Cited by 23
Moon, E., Oh, J., Kim, Y.-H., Ryoo, I., & Yoo, I. (2009) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.32.1689 · Cited by 26
Age-Related Changes of Gene Expression Profiles in Drosophila
Bordet, G., Lodhi, N., Kossenkov, A. V., & Tulin, A. V. (2021) · Genes · doi:10.3390/genes12121982 · Cited by 23
“Aging-related morbidity involves an increase in the risk for certain cancers [1,2], heart disease [3], macular degeneration [4], Alzheimer’s disease [5], osteoporosis [6], and a plethora of other conditions.”
BackgroundTelomeres and telomerase in T cells of tumor immunity
Qian, Y., Yang, L., & Cao, S. (2014) · Cellular Immunology · doi:10.1016/j.cellimm.2014.03.009 · Cited by 26
“Somatic cells have a limited number of cell divisions and, when telomeric ends become too short, DNA damage signals from telomeres can send signals to stop division and induce apoptosis through a process termed cellular senescence or replicative senescence [4,5].”
BackgroundAsk, T. F., Lugo, R. G., & Sütterlin, S. (2018) · Frontiers in Neuroscience · doi:10.3389/fnins.2018.00726 · Cited by 24
“Cellular senescence can happen to any mitotic cell in response to a variety of cellular stressors (Campisi, 2001, 2003); the claim made by the NISIM is merely that low trait prefrontal activity speeds up the accumulation of senescent cells.”
BackgroundYou, W., & Henneberg, M. (2018) · PubMed Central · doi:10.22034/apjcp.2018.19.8.2229 · Cited by 27
“Researches into the relationship between ageing and PC61 have revealed that, essentially, ageing process leads to the acquisition of mutations and the formation of a molecular and cellular environment which favours carcinogenesis (Majeed et al., 2000; Campisi, 2003; Shavers et al., 2009).”
BackgroundThe evolution of senescence through decelerating selection for system reliability
Laird, R. A., & Sherratt, T. N. (2009) · Journal of Evolutionary Biology · doi:10.1111/j.1420-9101.2009.01709.x · Cited by 23
“…acting late life can arise for much the same reason, when a series of checks and balances preventing cell proliferation within a typical lifespan can by chance all eventually become damaged, and the disease spreads (Armitage & Doll, 1954; Nunney, 1999, 2003; Campisi, 2003; Frank, 2004, 2007).”
BackgroundBernardini, D., Ballabio, E., Mariotti, M., & Maier, J. A. M. (2005) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2005.06.013 · Cited by 23
Marinovic‐Terzić, I., Yoshioka-Yamashita, A., Shimodaira, H., Avdievich, E., Hunton, I. C., Kolodner, R. D., Edelmann, W., & Wang, J. Y. J. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0806435105 · Cited by 22
Criteria to rationalize population screening to control oral cancer
Lavelle, C. L. B., & Scully, C. M. (2004) · Oral Oncology · doi:10.1016/j.oraloncology.2004.04.009 · Cited by 22
McColl, G., Vantipalli, M. C., & Lithgow, G. J. (2005) · The FASEB Journal · doi:10.1096/fj.04-2447fje · Cited by 25
Mouse and Human Cells Versus Oxygen
Hornsby, P. J. (2003) · Science of Aging Knowledge Environment · doi:10.1126/sageke.2003.30.pe21 · Cited by 22
The context-dependent effect of cellular senescence: From embryogenesis and wound healing to aging
Lavarti, R., Alvarez-Diaz, T., Marti, K., Kar, P., & Raju, R. P. (2025) · Ageing Research Reviews · doi:10.1016/j.arr.2025.102760 · Cited by 21
Wattanathamsan, O., Chetprayoon, P., Chantaravisoot, N., Wongkongkathep, P., Chanvorachote, P., & Pongrakhananon, V. (2021) · Cancer Medicine · doi:10.1002/cam4.4380 · Cited by 22
A short acidic motif in ARF guards against mitochondrial dysfunction and melanoma susceptibility
Christensen, C., Bártková, J., Mistrík, M., Hall, A., Lange, M. K., Ralfkiær, U., Bártek, J., & Guldberg, P. (2014) · Nature Communications · doi:10.1038/ncomms6348 · Cited by 23
Robert, L., & Labat‐Robert, J. (2013) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm-2012-0763 · Cited by 22
Eco‐evolutionary perspectives of the dynamic relationships linking senescence and cancer
Lemaître, J., Pavard, S., Giraudeau, M., Vincze, O., Jennings, G., Hamede, R., Újvári, B., & Thomas, F. (2019) · Functional Ecology · doi:10.1111/1365-2435.13394 · Cited by 22
“…alternative molecular pathways) cellular senescence and organismal aging (Rufini, Tucci, 445 Celardo, & Melino, 2013), leading to reduced tissue renewal and repair, stem cell deletion, 446 and organismal aging through an antagonistic pleiotropy effect (Campisi, 2003; García-Cao et 447 al., 2002).”
BackgroundFlamini, V., Jiang, W. G., Lane, J., & Cui, Y. (2016) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2016.02.010 · Cited by 26
Benonisdottir, S., Straub, V. J., Kong, A., & Mills, M. C. (2024) · Nature Aging · doi:10.1038/s43587-024-00733-w · Cited by 23
“Similarly, there is also an antagonistic pleiotropic relationship of cancer and longevity, and evolutionary theory provides a useful explanation for this paradoxical relationship of DDR genes in aging 89,100 .”
Biomarkers of UVB radiation-related senescent fibroblasts
Qiang, M., & Dai, Z. (2024) · Scientific Reports · doi:10.1038/s41598-023-51058-4 · Cited by 25
“In addition to impeding the body’s regenerative capacity, senescent cells may pose harm by releasing substances that disrupt tissue homeostasis 22,23 .”
BackgroundExpression of the tumour‐suppressor maspin in temporal bone carcinoma
Marioni, G., Zanoletti, E., Stritoni, P., Lionello, M., Giacomelli, L., Gianatti, A., Cattaneo, L., Blandamura, S., Mazzoni, A., & Martini, A. (2013) · Histopathology · doi:10.1111/his.12151 · Cited by 20
Kerber, R. A., O’Brien, E., Boucher, K. M., Smith, K. R., & Cawthon, R. (2012) · PLoS ONE · doi:10.1371/journal.pone.0034746 · Cited by 21
Senescence-Dependent MutSα Dysfunction Attenuates Mismatch Repair
Chang, I. Y., Jin, M., Yoon, S. P., Youn, C.-K., Yoon, Y. A., Moon, S.-P., Hyun, J. W., Jun, J. Y., & You, H. J. (2008) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-07-0380 · Cited by 23
pRb-E2F signaling in life of mesenchymal stem cells: Cell cycle, cell fate, and cell differentiation
Popov, B. V., & Ns, P. (2014) · Genes & Diseases · doi:10.1016/j.gendis.2014.09.007 · Cited by 21
“However, the structures of the ancestral pRb-E2fs molecules are more similar to p107/p130-E2f4,5 that play role of quiescence gate keepers in complex self-renewing organisms.(14) RB1 and E2F1-3 functions in development were related to diversification of cell cycle, regulation of apoptosis, metabolism and tumor suppres…”
BackgroundAl‐Khalaf, H. H., & Aboussekhra, A. (2012) · AGE · doi:10.1007/s11357-011-9378-2 · Cited by 23
“tissues, as aging of post-mitotic tissues is known to be associated with a general enhancement of apoptosis, and this trend seems to be essential for the removal of damaged and dysfunctional non-replaceable cells (Higami and Shimokawa 2000; Campisi 2003).”
BackgroundGenome instability: Cancer or aging?
Vijg, J., & Dollé, M. E. T. (2007) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2007.05.004 · Cited by 24
“Cancer presumably arose as a major aging-related adverse phenotype with the evolution of renewable tissues (Campisi, 2003).”
BackgroundEmergence of new infectious diseases
Woolhouse, M. E. J., & Antia, R. (2007) · Oxford University Press eBooks · doi:10.1093/acprof:oso/9780199207466.003.0016 · Cited by 21
Oncogene-dependent Tumor Suppression: Using the Dark Side of the Force for Cancer TherapyPreprint
Evan, G. I., CHRISTOPHOROU, M., LAWLOR, E. A., Ringshausen, I., Prescott, J. E., Dansen, T. B., Finch, A. J., Martins, C. P., & Murphy, D. J. (2005) · Cold Spring Harbor Symposia on Quantitative Biology · doi:10.1101/sqb.2005.70.054 · Cited by 19
“…for p53 and other tumor suppressors to exhibit “antagonistic pleiotropy”—in effect, an evolutionary compromise in which provision of effective tumor suppression up to reproductive age comes at the cost of eroding post-reproductive life span (Green and Evan 2002; Campisi 2003; Lowe et al. 2004).”
BackgroundFamilial Mortality in the Utah Population Database: Characterizing a Human Aging Phenotype
O’Brien, E. A., Kerber, R. A., Smith, K. R., Mineau, G., Boucher, K. M., & Reed, D. L. (2007) · The Journals of Gerontology Series A · doi:10.1093/gerona/62.8.803 · Cited by 18
“In this view, the later life pattern of most cancers signals a change from beneficial gene adaptations under strong selection in early life to deleterious effects in later life, postselection (33,34).”
BackgroundKLF2 induces the senescence of pancreatic cancer cells by cooperating with FOXO4 to upregulate p21
Yuedi, D., Houbao, L., Lu, P., Hui, W., Min, T., & Dexiang, Z. (2019) · Experimental Cell Research · doi:10.1016/j.yexcr.2019.111784 · Cited by 21
Mason, D. X., Keppler, D., Zhang, J., Jackson, T. J., Seger, Y. R., Matsui, S., Abreo, F., Cowell, J. K., Hannon, G. J., Lowe, S. W., et al. (2006) · Carcinogenesis · doi:10.1093/carcin/bgi264 · Cited by 18
“One important safeguard against neoplastic transformation is replicative senescence [3].”
BackgroundGlobal spatial patterns of infectious diseases and human evolution
Guégan, J., Prugnolle, F., & Thomas, F. (2007) · Oxford University Press eBooks · doi:10.1093/acprof:oso/9780199207466.003.0002 · Cited by 17
Harkness, T. A. A., Arnason, T., Legrand, C., Pisclevich, M. G., Davies, G. F., & Turner, E. L. (2005) · Eukaryotic Cell · doi:10.1128/ec.4.4.673-684.2005 · Cited by 19
“Premature aging in mammalian cells is often accompanied by cancer and genomic instability (7, 8 ). Strikingly, several reports have indicated that the APC plays a pivotal role in resistance to cancer (5, 53, 65).”
BackgroundCould stress granules be involved in age-related diseases?
Gallouzi, I. (2009) · Aging · doi:10.18632/aging.100090 · Cited by 22
“Since senescent cells remain metabolically active [7, 19], these stresses could cause dramatic changes in the expression pattern of key genes which could explain how and why as we age senescent cells switch their function to become promoters of tumor growth.”
BackgroundKoella, J. C., & Turner, P. E. (2007) · Oxford University Press eBooks · doi:10.1093/acprof:oso/9780199207466.003.0017 · Cited by 18
Intimate relations: Evolutionary conflicts of pregnancy and childhood
Haig, D. (2007) · Oxford University Press eBooks · doi:10.1093/acprof:oso/9780199207466.003.0006 · Cited by 19
Wounding Therapies for Prevention of Photocarcinogenesis
Frommeyer, T. C., Rohan, C. A., Spandau, D. F., Kemp, M. G., Wanner, M. A., Tanzi, E. L., & Travers, J. B. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2021.813132 · Cited by 17
A novel risk signature for predicting brain metastasis in patients with lung adenocarcinoma
Zhao, Y., Gu, S., Li, L., Zhao, R., Xie, S., Zhang, J., Zhou, R., Tu, L., Jiang, L., Zhang, S., et al. (2023) · Neuro-Oncology · doi:10.1093/neuonc/noad115 · Cited by 18
“28 29–31 In the study of melanoma, the aging microenvironment promotes metastasis through multiple mechanisms.”
BackgroundElimination of Senescent Cells: Prospects According to the Subtelomere-Telomere Theory
Libertini, G., Ferrara, N., Rengo, G., & Corbi, G. (2018) · Biochemistry (Moscow) · doi:10.1134/s0006297918120064 · Cited by 19
Is aging the price for memory?
Terman, A., & Brunk, U. T. (2005) · Biogerontology · doi:10.1007/s10522-005-7956-3 · Cited by 17
“Non-lethal nuclear and mitochondrial DNA mutations may accumulate in proliferative tissues with age (Turker 2000; Taylor et al. 2003), some resulting in the development of malignant neoplasms (Campisi 2003).”
BackgroundItzhaki, O., Kaptzan, T., Skutelsky, E., Sinai, J., Michowitz, M., Siegal, A., Schibi, G., Huszar, M., Ben-Dor, L., & Leibovici, J. (2003) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2003.11.009 · Cited by 16
Metadata
- Authors
- Campisi, J.
- Affiliations
- Lawrence Berkeley National Laboratory (US)
- Corresponding author
- Campisi, Judith
- ORCID
- Campisi, Judith
- Venue
- Nature Reviews Cancer
- Published
- 2003-05
- Volume
- 3
- Issue
- 5
- Pages
- 339-349
- ISSN
- 1474-175X (ISSN-L)
- 1474-1768
- OpenAlex
- W2096846805
- Cited by
- 512
- References
- 158
- Citations by year
- 2026: 5 · 2025: 10 · 2024: 9 · 2023: 12 · 2022: 14 · 2021: 15 · 2020: 10 · 2019: 10 · 2018: 18 · 2017: 19 · 2016: 16 · 2015: 23 · 2014: 20 · 2013: 19 · 2012: 23
- FWCI
- 2.72
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature reviews. Cancer (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Aging › Genetics, Aging, and Longevity in Model Organisms
- Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Telomeres, Telomerase, and Senescence
- Keywords
- cancer, aging, tumor suppressor pathways, somatic maintenance, embryonic development
- MeSH terms
- Aging, DNA Repair, Humans, Longevity, Neoplasms, Tumor Suppressor Protein p53, Retinoblastoma Protein, Cellular Senescence, Apoptosis, Genomics
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.